PAM
Paradigm Asset Management’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.9K | Hold |
1,200
| – | – | 0.02% | 344 |
|
|
2025
Q1 | $88.2K | Hold |
1,200
| – | – | 0.02% | 341 |
|
|
2024
Q4 | $78.6K | Sell |
1,200
-200
| -14% | -$13.1K | 0.02% | 343 |
|
|
2024
Q3 | $109K | Sell |
1,400
-200
| -13% | -$15.6K | 0.03% | 321 |
|
|
2024
Q2 | $125K | Hold |
1,600
| – | – | 0.03% | 301 |
|
|
2024
Q1 | $108K | Hold |
1,600
| – | – | 0.03% | 341 |
|
|
2023
Q4 | $108K | Hold |
1,600
| – | – | 0.03% | 340 |
|
|
2023
Q3 | $108K | Buy |
1,600
+400
| +33% | +$27.1K | 0.03% | 339 |
|
|
2023
Q2 | $85.9K | Hold |
1,200
| – | – | 0.02% | 350 |
|
|
2023
Q1 | $83.3K | Hold |
1,200
| – | – | 0.02% | 368 |
|
|
2022
Q4 | $81.4K | Hold |
1,200
| – | – | 0.02% | 380 |
|
|
2022
Q3 | $65.8K | Buy |
+1,200
| New | +$65.8K | 0.02% | 370 |
|
|
2022
Q2 | – | Sell |
-3,454
| Closed | -$229K | – | 398 |
|
|
2022
Q1 | $229K | Hold |
3,454
| – | – | 0.06% | 282 |
|
|
2021
Q4 | $201K | Sell |
3,454
-500
| -13% | -$29.1K | 0.05% | 297 |
|
|
2021
Q3 | $237K | Buy |
+3,954
| New | +$237K | 0.07% | 294 |
|
|
2014
Q3 | – | Sell |
-700
| Closed | -$52K | – | 787 |
|
|
2014
Q2 | $52K | Hold |
700
| – | – | 0.01% | 722 |
|
|
2014
Q1 | $45.4K | Sell |
700
-200
| -22% | -$13K | 0.01% | 710 |
|
|
2013
Q4 | $53.4K | Hold |
900
| – | – | 0.01% | 683 |
|
|
2013
Q3 | $46.7K | Sell |
900
-1,400
| -61% | -$72.7K | 0.01% | 714 |
|
|
2013
Q2 | $109K | Buy |
+2,300
| New | +$109K | 0.02% | 559 |
|